Ingo Klette

1.7k total citations · 2 hit papers
21 papers, 1.3k citations indexed

About

Ingo Klette is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ingo Klette has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Ingo Klette's work include Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (7 papers) and Peptidase Inhibition and Analysis (7 papers). Ingo Klette is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (7 papers) and Peptidase Inhibition and Analysis (7 papers). Ingo Klette collaborates with scholars based in Germany, Netherlands and Switzerland. Ingo Klette's co-authors include Richard P. Baum, Harshad Kulkarni, Hans‐Jürgen Wester, Margret Schottelius, Dirk Müeller, Aviral Singh, Stefan Wiessalla, Christiane Schuchardt, Martina Wirtz and Martina Weineisen and has published in prestigious journals such as Nature Protocols, Chemistry - A European Journal and Dalton Transactions.

In The Last Decade

Ingo Klette

21 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

2015 419 citations Martina Weineisen, Margret Schottelius et al. Journal of Nuclear Medicine profile →
¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

2016 397 citations Richard P. Baum, Harshad Kulkarni et al. Journal of Nuclear Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ingo Klette	1.1k	842	458	173	129	21	1.3k
Elisabeth Eppard	1.6k 1.5×	1.3k 1.6×	708 1.5×	170 1.0×	167 1.3×	48	2.0k
Christiane Schuchardt	1.3k 1.2×	877 1.0×	867 1.9×	379 2.2×	185 1.4×	42	1.8k
Christoph A. Umbricht	974 0.9×	702 0.8×	333 0.7×	83 0.5×	84 0.7×	15	1.1k
Jakub Šimeček	1.1k 1.0×	662 0.8×	526 1.1×	108 0.6×	135 1.0×	29	1.4k
Germo Gericke	1.0k 1.0×	1.2k 1.4×	563 1.2×	168 1.0×	174 1.3×	6	1.6k
Ute Hennrich	717 0.7×	474 0.6×	436 1.0×	195 1.1×	181 1.4×	12	1.1k
Calogero D’Alessandria	1.4k 1.3×	1.1k 1.3×	749 1.6×	183 1.1×	252 2.0×	77	2.1k
Chandler H. Park	1.1k 1.0×	1.2k 1.4×	602 1.3×	127 0.7×	186 1.4×	20	1.7k
Stephan Maus	851 0.8×	719 0.9×	284 0.6×	76 0.4×	91 0.7×	67	1.1k
Jessie R. Nedrow	815 0.8×	420 0.5×	497 1.1×	80 0.5×	233 1.8×	37	1.3k

Countries citing papers authored by Ingo Klette

Since Specialization

Citations

This map shows the geographic impact of Ingo Klette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Klette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Klette more than expected).

Fields of papers citing papers by Ingo Klette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Klette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Klette. The network helps show where Ingo Klette may publish in the future.

Co-authorship network of co-authors of Ingo Klette

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Klette. A scholar is included among the top collaborators of Ingo Klette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Klette. Ingo Klette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Aviral, Nicholas P. van der Meulen, Cristina Müller, et al.. (2017). First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced ⁴⁴ Sc-DOTATOC: A Proof-of-Concept Study. Cancer Biotherapy and Radiopharmaceuticals. 32(4). 124–132. 52 indexed citations

Baum, Richard P., Aviral Singh, Christiane Schuchardt, et al.. (2017). ¹⁷⁷Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results. Journal of Nuclear Medicine. 59(5). 809–814. 58 indexed citations

Müeller, Dirk, Wouter A.P. Breeman, Ingo Klette, et al.. (2016). Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method. Nature Protocols. 11(6). 1057–1066. 50 indexed citations

Baum, Richard P., Harshad Kulkarni, Christiane Schuchardt, et al.. (2016). ¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. Journal of Nuclear Medicine. 57(7). 1006–1013. 397 indexed citations breakdown →

Nock, Berthold A., Aikaterini Kaloudi, Harshad Kulkarni, et al.. (2016). Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results. Journal of Nuclear Medicine. 58(1). 75–80. 126 indexed citations

Singh, Aviral, Harshad Kulkarni, Ingo Klette, & Richard P. Baum. (2016). Clinical application of Cu-64 PSMA PET/CT in Theranostics of prostate cancer. 57. 1538–1538. 7 indexed citations

Weineisen, Martina, Margret Schottelius, Jakub Šimeček, et al.. (2015). ⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies. Journal of Nuclear Medicine. 56(8). 1169–1176. 419 indexed citations breakdown →

Baum, Richard P., Harshad Kulkarni, K. H. Bohuslavizki, et al.. (2015). Theranostik des metastasierten Prostatakarzinoms mittels Lu-177 PSMA-Liganden in Kombination mit Ga-68 PSMA PET/CT. Der Nuklearmediziner. 38(2). 145–152. 5 indexed citations

Singh, Aviral, et al.. (2015). Scandium-44 DOTATOC PET/CT: First in-human molecular imaging of neuroendocrine tumors and possible perspectives for Theranostics. 56. 267–267. 14 indexed citations

10.

Schuchardt, Christiane, Martina Weineisen, Stefan Wiessalla, et al.. (2014). Biodistribution and dosimetry of Lu-177 PSMA in metastasized castrate resistant prostate cancer patients. 55. 641–641. 2 indexed citations

11.

Müeller, Dirk, Ingo Klette, & Richard P. Baum. (2013). Clinical routine production of 177Lu-BPAMD. 54(2). 1191–1191. 2 indexed citations

12.

Müeller, Dirk, et al.. (2013). Correction to Simplified NaCl Based ⁶⁸Ga Concentration and Labeling Procedure for Rapid Synthesis of ⁶⁸Ga Radiopharmaceuticals in High Radiochemical Purity. Bioconjugate Chemistry. 24(11). 1969–1969. 1 indexed citations

13.

Müeller, Dirk, Ingo Klette, & Richard P. Baum. (2013). Combined cationic-anionic pre-purification of 68Ga for the synthesis and clinical application of 68Ga-BPAMD. 54. 1190–1190. 1 indexed citations

14.

Müeller, Dirk, Ingo Klette, & Richard P. Baum. (2012). Purification and Labeling Strategies for 68Ga from 68Ge/68Ga Generator Eluate. Recent results in cancer research. 194. 77–87. 11 indexed citations

15.

Müeller, Dirk, Ingo Klette, Richard P. Baum, et al.. (2012). Simplified NaCl Based ⁶⁸Ga Concentration and Labeling Procedure for Rapid Synthesis of ⁶⁸Ga Radiopharmaceuticals in High Radiochemical Purity. Bioconjugate Chemistry. 23(8). 1712–1717. 105 indexed citations

16.

Müeller, Dirk, et al.. (2011). Synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine based on a cartridge purification method. Nuclear Medicine and Biology. 38(5). 653–658. 19 indexed citations

17.

Gottschaldt, Michael, Dirk Müller, Ingo Klette, et al.. (2009). Rhenium and 99m-technetium complexes of monosaccharide based tripodal triamines as potential radio imaging agents. Dalton Transactions. 5148–5148. 7 indexed citations

18.

Gottschaldt, Michael, Helmar Görls, Martin Walther, et al.. (2009). In^III and Ga^III Complexes of Sugar‐Substituted Tripodal Trisalicylidene Imines: The First ⁶⁸Ga‐Labelled Sugar Derivative. European Journal of Inorganic Chemistry. 2009(28). 4298–4307. 3 indexed citations

19.

Gottschaldt, Michael, Daniel Koth, Dirk Müller, et al.. (2007). Synthesis and Structure of Novel Sugar‐Substituted Bipyridine Complexes of Rhenium and 99m‐Technetium. Chemistry - A European Journal. 13(36). 10273–10280. 42 indexed citations

20.

Piel, Markus, et al.. (2007). Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging. Bioorganic & Medicinal Chemistry. 15(9). 3171–3175. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact